Rachel Riechelmann: Excellent discussion of neoadjuvant IO in colorectal cancer
Rachel Riechelmann shared on X:
“Excellent discussion of neoadjuvant IO in colorectal cancer by Juan O’Connor at ESMOGI24.
Most patients but not all with pCR/cCR with ipi/nivo (MSI/MSS) by Kristen Ciombor (great trial!) and ctDNA (- 8% relapse even ctDNA- / immumoscore high) by Julien Taieb.”
Source: Rachel Riechelmann/X
Dr. Rachel Riechelmann is the Director of the Clinical Oncology Department and Professor at AC Camargo Cancer Center, Sao Paulo, Brazil and also serves as the President of the Brazilian GI Tumors Group (GTG).
She has more than 125 publications in peer-reviewed journals and is editor of the book Methods and Biostatistics in Oncology: Understanding Clinical Research as an Applied Tool, Springer 2018.
Prof. Riechelmann is a member of ESMO Scientific Committees (Colorectal and NET), Latin American Society of GI Oncology (SLAGO), the European Society of Neuroendocrine Tumors Advisory Board and Chair – GI LACOG (Latin American Cooperative Oncology Group).
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023